Clinical Trials Logo

Clinical Trial Summary

This study evaluates the efficacy and mechanism of internet-based cognitive training in patients with amnestic mild cognitive impairment (aMCI). Half of participants will receive multi-domain adaptive internet-based training program, while the other half will receive a fixed, primary difficulty level task.


Clinical Trial Description

Background: Alzheimer's disease (AD) is the most common dementia and the major cause for senile dementia. With the increase of life expectancy, AD has become a global problem. However, to date, drug therapies only have modest benefits for patients with AD. Recently, researchers have begun to focus on early intervention of AD at its preclinical stages. Individuals with amnestic mild cognitive impairment (aMCI), often the prodromal stage of AD, report mild short-term memory difficulties but preserved independence in activities of daily living. The aMCI stage is important to slow or even prevent the development of AD. Some previous studies have suggested cognitive training is a potential non-pharmacological intervention for aMCI, however, the results were inconsistent. Thus, investigators will conduct this multi-center randomized controlled trial to explore whether and how cognitive training improves cognitive function in patients with aMCI. Objectives: The first aim of this multi-center single-blinded, randomized controlled trial is to assess whether internet-based cognitive training improves cognitive abilities in patients with aMCI. Furthermore, the second objective is to evaluate the effect of cognitive training on neural plasticity, including brain activation and white matter integrity, which are assessed by functional and structural MRI. Patients and Methods: The study will include 260 patients diagnosed with aMCI from eight centers around China. The patients will be randomized to either a cognitive training group or an active-control group. The intervention is 12-week internet-based cognitive training performed for 40 minutes per day, 4 days a week. Within each task, high accuracy (80%) is required to upgrade to the next difficulty level. The active- control group will receive five processing speed and attention tasks, whose duration also total to 40 min each training day. However, these tasks are set to a fixed, primary difficulty level across the study. Neuropsychological assessments and structural and functional magnetic resonance imaging (MRI) will be performed at the baseline, end of intervention, and 6 months after randomization to measure long-term resilience of the effect. Relevance: Early intervention of aMCI has the potential to delay or even prevent the development of dementia. Some previous studies have suggested cognitive training is a potential non-pharmacological intervention for aMCI, however, the results were inconsistent. Thus, the proposed study is to determine the efficacy of cognitive training in patients with aMCI. Secondly, using functional and structural MRI, this study is to reveal the potential mechanisms underlying cognitive training. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04063956
Study type Interventional
Source Xuanwu Hospital, Beijing
Contact Yi Tang, M.D., Ph.D.
Phone 008613811021432
Email tangyixw@vip.163.com
Status Recruiting
Phase N/A
Start date November 6, 2019
Completion date December 2023

See also
  Status Clinical Trial Phase
Completed NCT01525368 - Outcome Predictors of a Cognitive Intervention in aMCI N/A
Completed NCT00785759 - Brain Uptake and Safety With Probable Alzheimer's Disease, Amnestic Mild Cognitive Impairment and Healthy Volunteers Phase 2
Recruiting NCT05903573 - Training Response Artificial Intelligence Network (TRAIN) N/A
Completed NCT02562989 - [18F]MK-6240 Positron Emission Tomography (PET) Tracer First-in-Human Validation Study (MK-6240-001) Phase 1
Completed NCT02910739 - An Open-Label Study Investigating MK-8931 in Participants With Mild and Moderate Hepatic Insufficiency (MK-8931-016) Phase 1
Not yet recruiting NCT04103463 - Interactive Stepping Exercise on Memory N/A
Completed NCT04185298 - mSIM: Mobile Simultaneous Aerobic Exercise and Memory Training Intervention for Amnestic Mild Cognitive Impairment N/A
Terminated NCT01953601 - Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019) Phase 3
Recruiting NCT06041152 - Does Psilocybin Change Synaptic Density in Amnestic Mild Cognitive Impairment Phase 2
Completed NCT01962038 - A Combined Training Program for Veterans With Amnestic Mild Cognitive Impairment N/A
Recruiting NCT06444568 - Modified Ketogenic Diet in Amnestic Mild Cognitive Impairments N/A
Recruiting NCT03133052 - CTA-MCI: Cognitive Control Training in Patients With Amnestic Mild Cognitive Impairment(CTA-MCI) N/A
Not yet recruiting NCT05987007 - Sleep Interventions and Neurocognitive Outcomes N/A
Recruiting NCT04240561 - Characterizing Variability in Hearing Aid Outcomes in Among Older Adults With Alzheimer's Dementia N/A
Completed NCT01767909 - The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF) Phase 2/Phase 3
Terminated NCT01072812 - Study of the Pharmacokinetics and Pharmacodynamics of POSIPHEN® in Subjects With Amnestic Mild Cognitive Impairment Phase 1
Completed NCT00643266 - Recollection Training in Healthy Older Adults and Older Adults With Amnestic Mild Cognitive Impairment N/A
Active, not recruiting NCT04504630 - Noninvasive Brain Stimulation on Memory in Individuals With Mild Cognitive Impairment and History of Brain Injury N/A
Terminated NCT00582855 - Effect of AQW051 in Patients With Memory Impairment Phase 2
Recruiting NCT05446584 - Pathways Relating Amnestic MCI to a Mild Traumatic Brain Injury History Phase 2